CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer

Kyriakos P. Papadopoulos, Janet Ayello, Robert F. Reiss, Andrea Troxel, Elizabeth Kaufman, Linda T. Vahdat, Karen H. Antman, Charles S. Hesdorffer

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'CD34<sup>+</sup> cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences